Built at the Internet Archive
Creator
Sort By:
Sites and collections from this organization are listed below. Narrow your results at left, or enter a search query below to find a collection, site, specific URL or to search the text of archived webpages.
Page 1 of 1 (20 Total Results)
Sort By:
Collection: Drug Industry Web Archive
Description: Three part series on the beginnings of the opioid crisis and how it led to the heroin crisis: Purdue Pharma and El Chapo had provided kindling: The pharma company’s unprecedented marketing campaign for its blockbuster OxyContin painkiller did not stop with pill sales. Purdue marketing helped ensure that for the first time in U.S. history, heavy doses of one of the most addictive substances known to man would be prescribed by family doctors for everything from sprained ankles to migraines. Mexican drug kingpin Joaquin “El Chapo” Guzman, long focused on marijuana and transporting South American cocaine, took note of America’s new-found appetite for narcotics and began seeding mountainsides with poppy plants, the source of heroin. But it took Florida to set the heroin epidemic ablaze, a Palm Beach Post investigation has found. For years, Florida’s repeated failure to rein in its homegrown prescription painkiller scourge nourished a bumper crop of opioid addicts and dealers. It was widely reported that rogue clinics in Palm Beach and Broward counties funneled OxyContin and fueled addiction in Kentucky, Ohio, Georgia, Tennessee, the Carolinas and West Virginia. It was much worse. DEA reports and federal court records show that by 2010, Florida was the reliable opioid dealer of choice to users and dealers in not only the Southeast, but also in the Northeast, Mid-Atlantic and Great Lakes regions — an area spanning virtually every state east of the Mississippi River. And when Florida finally turned off the free-flowing oxycodone spigot in 2011, drug users in states once fed by Florida oxycodone did exactly what users in Palm Beach County and Florida did: They turned to heroin.
Loading Wayback Capture Info...
Loading video data...
Subject: opioids, pill mill, heroin, OxyContin, Purdue Pharma, El Chapo, Florida, addiction
Creator: Palm Beach Post
Collector: UCSF Industry Documents Library
Collection: Drug Industry Web Archive
Description: Article featuring Purdue Pharma internal budget documents for their opioid painkiller OxyContin from 1996 to 2002. These documents are a part of the Opioid Industry Documents Archive. These files were collected from the Florida Attorney General’s office after the South Florida Sun-Sentinel and Orlando Sentinel won a lawsuit seeking to make them public.
Loading Wayback Capture Info...
Loading video data...
Subject: OxyContin; Purdue Pharma; internal documents
Creator: Fred Schulte; Kaiser Health News
Collector: UCSF Industry Documents Library
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Description: During the height of the prescription opioid crisis in the United States, Insys Therapeutics, Inc., adopted and intensified sales and marketing techniques Purdue Pharma pioneered in the 1990s for OxyContin and applied them to Insys’ powerful fentanyl drug Subsys. Like Purdue, Insys aggressively used speakers programs—in which the company paid physicians to discuss Subsys with colleagues—and compensation programs for sales representatives to boost sales for Subsys. Based on a review of 1.6 million pages of internal Insys documents provided in response to March 2017 requests from Ranking Member McCaskill, this report discusses how the interplay between compensation—for physicians on the one hand and their assigned sales representatives on the other—drove explosive growth for Insys
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Description: Code of Personal Professional Responsibility added to the McKinsey website in June of 2019 McKinsey and Company document on their Code of Professional Conduct, which defines a set of expectations for the behavior of all firm members. 'The Code of Professional Conduct does not replace our policies. Rather, it serves as a guide to help colleagues understand the core elements of our policies and how those policies are anchored in our values. The Code of Professional Conduct highlights our personal responsibility for professional conduct. We expect all colleagues to comply with this Code of Professional Conduct and we expect others working on our behalf, such as contractors, advisors and other suppliers, to act in a manner that is consistent with our Code'
Loading Wayback Capture Info...
Loading video data...
Subject: ethics, values, policy, corporate social responsibility
Creator: McKinsey and Company
Collector: UCSF Industry Documents Library
Collection: Drug Industry Web Archive
Description: Company-produced communication containing 8 articles discussing perspectives on the evolution of pharmaceutical field based selling
Loading Wayback Capture Info...
Loading video data...
Subject: sales, smart field force, corporatized healthcare providers, engagement tactics, formulary gains, commercial support services, patient services
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Subject: opioids, consulting, marketing and sales, FDA
Creator: NY Times
Collector: UCSF Industry Documents Library
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Subject: Purdue Pharma, OxyContin, opioids, interview
Creator: The Guardian
Collector: UCSF Industry Documents Library
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Subject: opioids; opioid crisis; internal documents; sales and marketing
Creator: Washington Post
Collector: UCSF Industry Documents
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Collection: Drug Industry Web Archive
Description: Rap video with original song - Insys Pharmaceuticals reps on drug sales, titration, promotion of fentanyl
Loading Wayback Capture Info...
Loading video data...
Subject: opioids, fentanyl, sales representatives, marketing, titration
Creator: Insys
Collector: UCSF Industry Documents Library
Collection: Drug Industry Web Archive
Loading Wayback Capture Info...
Loading video data...
Page 1 of 1 (20 Total Results)